Chimera Investment Corporation
NYSE:CIMREIT - Mortgage
+$0.12 today
- Market cap
- $541.62M
- Beta
- 1.76
- P/E (TTM)
- 58.1
- EPS (TTM)
- $0.23
- Dividend yield
- 11.65%
Volume 1.98M
Average 0.70M
CIM Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Chimera Investment CorporationNYSE: CIM
Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026
Cost of revenue grows, but more slowly than its trailing trend
Q1 FY2026 cost of revenue of $147.12M rose 17.9% year over year, behind the +147.2% change in trailing-twelve-month cost of revenue. Sequentially, it rose 902.5% from the prior quarter.
Context
- Cost of revenue amounted to 5.1% of revenue in FY2025, up 5.1 pp from a year earlier.
- Cost of revenue increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +17.9% toward the trailing-twelve-month pace of +147.2%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 42.1M USD
- Year-over-year change
- —
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 42.1M | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Cost of Revenue vs competitors
How CIM compares with its peers on the latest reported figures
- CIM's LTM Mar 2026 cost of revenue of $308.47M is the 3rd highest of the 9 companies compared; the peer median is $106.07M.
- Its year-over-year change of +147.2% is the 4th highest of 8, against a peer median of +95.8%.
- Cost of revenue amounts to 48.5% of revenue for CIM, versus a peer median of 20.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $1.46B | +2635.2% | -49.2% | 18.8% | |
| LTM Sep 2026 | $750M | +1.2% | — | 21.4% | |
| LTM Mar 2026 | $308.47M | +147.2% | — | 48.5% | |
| LTM Mar 2026 | $275.05M | +2390.5% | -8.0% | 38.4% | |
| LTM Mar 2026 | $113.98M | +95.8% | +135.2% | 40.6% | |
| LTM Mar 2026 | $98.17M | — | +11.6% | 29.0% | |
| LTM Mar 2026 | $92.03M | +370.2% | -48.7% | 12.0% | |
| LTM Mar 2026 | $89.62M | +34.8% | +9.9% | 7.4% | |
| LTM Jun 2026 | $32.55M | -7.9% | +14.4% | 4.1% | |
| Peer median (excluding CIM) | $106.07M | +95.8% | +9.9% | 20.1% | |
Competitors are the stored peer set for CIM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.06B | (415.21M) | 204.77M | 257.93M | 820.77M |
| Cost of Revenue | 0 | 0 | 0 | 0 | 42.1M |
| Gross Profit | 1.06B | (415.21M) | 204.77M | 257.93M | 778.67M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 94.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 69.07M | 72.03M | 55.69M | 64.57M | 30M |
| Operating Expenses | 1.06B | (415.21M) | 204.77M | 257.93M | 14.01M |
| Depreciation & Amortization | 70.58M | 61.49M | 0 | 321K | 7.18M |
| EBITDA | 1.07B | (118.54M) | 635.75M | 672.71M | 794.87M |
| EBITDA Margin | 101.4% | 28.5% | 310.5% | 260.8% | 96.8% |
| Operating Income | 0 | 0 | 0 | 0 | 764.65M |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 93.2% |
| Interest Income | 937.55M | 773.12M | 772.9M | 760.95M | 821.86M |
| Interest Expense | 326.63M | 333.29M | 509.54M | 496.27M | 554.92M |
| Other Income / Expenses | 674.52M | (513.32M) | 126.21M | 176.11M | (531.89M) |
| Income Before Tax | 674.52M | (513.32M) | 126.21M | 176.11M | 232.77M |
| Pre-Tax Margin | 63.8% | 123.6% | 61.6% | 68.3% | 28.4% |
| Income Tax Expense | 4.41M | (253K) | 102K | 49K | 2.27M |
| Net Income | 670.11M | (513.07M) | 126.1M | 176.07M | 230.5M |
| Net Margin | 63.4% | 123.6% | 61.6% | 68.3% | 28.1% |
| EPS (Basic) | 7.65 | (2.19) | 0.55 | 1.12 | 2.80 |
| EPS (Diluted) | 2.43 | (2.19) | 0.54 | 1.10 | 2.75 |
| Weighted Avg Shares | 77.92M | 77.98M | 76.64M | 80.99M | 82.18M |
| Weighted Avg Shares (Diluted) | 81.83M | 77.98M | 78.14M | 82.16M | 83.94M |
Chimera Investment Corporation
NYSE:CIM
Intrinsic Alpha fair value
Locked
Current Price
$6.47
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.